arrow
M

Martin Misch

charité-universitätsmedizin berlin
H指数:26
被引数:2,771

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PTEN homozygous deletion is a negative prognostic factor in tumor treating fields-treated glioblastoma, IDH wildtype patients

PTEN纯合子缺失是肿瘤治疗电场治疗胶质母细胞瘤,IDH野生型患者的负性预后因素

2026-09-110
OAAI
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial

IDH1突变疫苗在新诊断星形细胞瘤中的应用:多中心、单臂、开放标签、首次人体1期NOA16试验的最终分析

2026-07-010
OAAI
High-Dose Stereotactic Re-Irradiation of Recurrent High-Grade Gliomas: Clinical Outcome and Experience with AI-Based Target Volume Simulation

高剂量立体定向再程放疗治疗复发性高级别胶质瘤:基于AI靶区模拟的临床结果与经验

Cancers
IF4.4
2026-03-030
OAAI
PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients

PTEN纯合性缺失是接受肿瘤治疗电场治疗的IDH野生型胶质母细胞瘤患者的预后不良因素。

2025-11-010
OAAI
Physician-led versus questionnaire-based psychosocial screening in adults with high-grade glioma: a cluster-randomized controlled trial (GLIOPT)

医生主导与问卷为基础的心理社会筛查在高级别胶质瘤成人患者中的比较:一项集群随机对照试验(GLIOPT)

2025-09-100
OAAI
Distress screening in patients with high-grade glioma: diagnostic accuracy in relation to a structured clinical interview in a multicenter cluster-randomized controlled trial

高级别胶质瘤患者的痛苦筛查:在多中心集群随机对照试验中,与结构化临床访谈相关的诊断准确性

2025-07-310
OA
Practice Variation in Perioperative Dexamethasone Use and Outcomes in Brain Metastasis Resection

脑转移瘤切除术围手术期地塞米松使用实践差异及其结局

2025-04-110
OA
Clinical characteristics and outcomes in leptomeningeal disease with or without brain metastasis: insights from an explorative data analysis of the Charité LMD registry

有或没有脑转移的软脑膜疾病的临床特征和结局: 来自charit é LMD注册中心的探索性数据分析的见解

2025-02-110
OAAI
Frequency and clinical associations of common mental disorders in adults with high-grade glioma-A multicenter study

成人高级别神经胶质瘤常见精神障碍的发生频率和临床关联-一项多中心研究

CANCER
IF5.1
2024-11-170
OAAI
A SEX-SPECIFIC EVALUATION OF EMOTIONAL PROBLEMS, UNMET NEEDS AND PSYCHIATRIC COMORBIDITY IN PATIENTS WITH HIGH-GRADE GLIOMAS - A MULTI-CENTER STUDY
2024-10-170
PRE
SYSTEMIC AND LOCAL THERAPIES BEFORE AND AFTER DIAGNOSIS OF LEPTOMENINGEAL DISEASE IN PATIENTS WITH BRAIN METASTASES: AN EXPLORATIVE, SINGLE-CENTER RETROSPECTIVE COHORT STUDY
2024-10-170
PRE
A INTEGRATED PSYCHOSOCIAL SCREENING LEADS TO ADEQUATE REFERRAL TO PSYCHOSOCIAL SERVICES COMPARED TO QUESTIONNAIRES IN ADULT PATIENTS WITH HIGH-GRADE GLIOMA: A CLUSTER RANDOMIZED CONTROLLED TRIAL (GLIOPT)
2024-10-170
PRE
IMPROVED OUTCOME PREDICTION AND GRADING OF THE NOVEL TUMOUR TYPE GLIOMATOSIS CEREBRI-LIKE GLIOMA, IDH-WILDTYPE (GCLG, IDH-WT)
2024-10-170
PRE
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas
2024-02-072
OAAI